Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic ...
Serum CXCL6 was higher in ANCA-associated vasculitis with interstitial lung disease and independently predicted ILD progression, suggesting a blood biomarker to identify AAV-ILD and monitor risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback